SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A
http://www.w3.org/2000/01/rdf-schema#comment
"Data suggest that systemic inhibition of MdmX is both a feasible therapeutic strategy for restoring p53 function in tumors that retain wild-type p53 and likely to be significantly safer than inhibition of Mdm2."
xsd:string
http://purl.uniprot.org/uniprot/#_703DC3AD5BE54B40663BB4F7C81B32906BF4C2E64B8E97CAF3995BDF40BA3E06C2402CAF073124A24268525FE2F9A418
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A
http://purl.uniprot.org/uniprot/Q3UTC9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A
http://purl.uniprot.org/uniprot/#_Q3UTC9-mappedCitation-21852537
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8293AC6C09BAC7DD2F67CE721DCAC45C0FF10BDF4B03B6BEB001F7670EAFB86C48B321B87B026E592EF709E2A12FE94A